Time trend of outcomes according to systemic therapy for patients with unresectable hepatocellular carcinoma: A single‐institution study
We consider that advancements in systemic therapy, along with changes in treatment strategies, such as sequential therapy after progression, contribute to the prolonged prognosis across different eras.
Authors
- Shinsuke Uchikawa (ORCID: https://orcid.org/0000-0002-1538-4946)
- Serami Murakami (ORCID: https://orcid.org/0009-0007-1260-0395)
- C. Nelson Hayes (ORCID: https://orcid.org/0000-0003-1691-3544)
- Eisuke Murakami (ORCID: https://orcid.org/0000-0003-0357-2795)
- Masataka Tsuge (ORCID: https://orcid.org/0000-0001-7591-8287)
- Tomokazu Kawaoka (ORCID: https://orcid.org/0000-0002-1887-1096)
- Shiro Oka (ORCID: https://orcid.org/0000-0002-1652-0743)
- Daiki Miki (ORCID: https://orcid.org/0000-0002-6505-9826)
- Yusuke Johira (ORCID: https://orcid.org/0000-0002-4521-5887)
- Masanari Kosaka (ORCID: https://orcid.org/0009-0006-6374-4965)
- Yuki Shirane
- Atsushi Ono (ORCID: https://orcid.org/0000-0002-2482-945X)
- Hatsue Fujino (ORCID: https://orcid.org/0000-0002-9691-4960)
- Yasutoshi Fujii (ORCID: https://orcid.org/0000-0002-3967-6687)
- Ryoichi Miura
Institutions
- Hiroshima University Hospital (JP)
Publication Details
- Journal
- Hepatology Research
- Published
- 2024-10-26
- DOI
- https://doi.org/10.1111/hepr.14130
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.74